Journal
MOLECULAR AND CELLULAR BIOLOGY
Volume 34, Issue 1, Pages 30-42Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.01169-13
Keywords
-
Categories
Funding
- Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)
- MEXT
- Japan Society for the Promotion of Science
- Grants-in-Aid for Scientific Research [23510254, 24591313] Funding Source: KAKEN
Ask authors/readers for more resources
Hypoxia-inducible factor 1 (HIF-1) plays a key role in the cellular adaptation to hypoxia. Although HIF-1 is usually strongly suppressed by posttranslational mechanisms during normoxia, HIF-1 is active and enhances tumorigenicity in malignant tumor cells that express the membrane protease MT1-MMP. The cytoplasmic tail of MT1-MMP, which can bind a HIF-1 suppressor protein called factor inhibiting HIF-1 (FIH-1), promotes inhibition of FIH-1 by Mint3 during normoxia. To explore possible links between HIF-1 activation by MT1-MMP/Mint3 and tumor growth signals, we surveyed a panel of 252 signaling inhibitors. The mTOR inhibitor rapamycin was identified as a possible modulator, and it inhibited the mTOR-dependent phosphorylation of Mint3 that is required for FIH-1 inhibition. A mutant Mint3 protein that cannot be phosphorylated exhibited a reduced ability to inhibit FIH-1 and promoted tumor formation in mice. These data suggest a novel molecular link between the important hub proteins MT1-MMP and mTOR that contributes to tumor malignancy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available